Generated by AI
Scilex Holding Co. is a commercial biopharmaceutical company focused on developing and marketing non-opioid pain management products for acute and chronic pain. Its current portfolio includes ZTlido, a topical lidocaine patch used for neuropathic pain linked to postherpetic neuralgia, ELYXYB, an oral solution for the acute treatment of migraine in adults, and GLOPERBA, a liquid oral colchicine product for gout flare prophylaxis. The company operates in the healthcare and pharmaceuticals market, serving the need for alternatives to opioid-based therapies through prescription products designed for targeted pain conditions. Scilex Holding Co. also works across product acquisition, development, and commercialization, giving it a role in both specialty pain treatment and broader pharmaceutical distribution. Based in Palo Alto, California, the company is positioned within the non-opioid pain management segment of the biopharmaceutical industry.
Website960 San Antonio Road
Palo Alto, CA, 94303
United States
The latest articles about SCLX.
Datavault AI says it has been unable to withdraw its Bitcoin from Biconomy since June and will restate four financial reports.
The company said the accounting correction will cut reported assets by $92.2 million at the end of 2025 after bitcoin held on Biconomy could not be withdrawn.
Summary of Nov 19's posts. Generated by AI.
Summary of Nov 21's posts. Generated by AI.
Summary of Jul 6's posts. Generated by AI.
Summary of Aug 1's posts. Generated by AI.
Investors talking about SCLX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.